A Study of Mirikizumab in Healthy Participants
Clinical trial NCT04607733 · COMPLETED
Trial details
- NCT number
- NCT04607733
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2021-05-17
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.